CVE-2015-5607

Public Exploit

Description

Cross-site request forgery in the REST API in IPython 2 and 3.

Category

8.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://bugzilla.redhat.com/show_bug.cgi?id=1243842 issue tracking patch
http://lists.fedoraproject.org/pipermail/package-announce/2015-July/162671.html issue tracking third party advisory vendor advisory
http://lists.fedoraproject.org/pipermail/package-announce/2015-July/162936.html issue tracking third party advisory vendor advisory
https://github.com/ipython/ipython/commit/1415a9710407e7c14900531813c15ba6165f0816 third party advisory patch
https://github.com/ipython/ipython/commit/a05fe052a18810e92d9be8c1185952c13fe4e5b0 third party advisory patch
http://www.openwall.com/lists/oss-security/2015/07/21/3 mailing list patch exploit third party advisory

Frequently Asked Questions

What is the severity of CVE-2015-5607?
CVE-2015-5607 has been scored as a high severity vulnerability.
How to fix CVE-2015-5607?
To fix CVE-2015-5607, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-5607 being actively exploited in the wild?
It is possible that CVE-2015-5607 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.